Showing results (1401-1410 of 2,107) with videos related to
Sort By:
Pageof 211
CNS Drugs|May 28, 2013
Management of chronic depressive patients with residual symptomsChangsu Han, Tzung Lieh Yeh, Masaki Kato, et al.CNS Drugs|February 26, 2013
Antipsychotic interventions in prodromal psychosis: safety issuesChen-Chung Liu, Arsime DemjahaCNS Drugs|May 10, 2013
Role of orexin in the pathophysiology of depression: potential for pharmacological interventionMathieu Nollet, Samuel LemanCNS Drugs|May 10, 2013
Induction therapy for patients with multiple sclerosis: why? When? How?Gilles Edan, Emmanuelle Le PageCNS Drugs|June 11, 2013
Pharmacological management of bipolar depression: acute treatment, maintenance, and prophylaxisEduard Vieta, Marc ValentíCNS Drugs|April 27, 2013
Dihydroergotamine: a review of formulation approaches for the acute treatment of migraineStephen D Silberstein, Shashidhar H KoriCNS Drugs|January 25, 2013
A revisited strategy for antiepileptic drug development in children: designing an initial exploratory stepCatherine Chiron, Behrouz Kassai, Olivier Dulac, et al.CNS Drugs|August 15, 2014
A review of OROS methylphenidate (Concerta(®)) in the treatment of attention-deficit/hyperactivity disorderMartin A Katzman, Tia SternatCNS Drugs|August 21, 2014
Health-related quality of life and functional outcomes from a randomized-withdrawal study of long-term lisdexamfetamine dimesylate treatment in children and adolescents with attention-deficit/hyperactivity disorderTobias Banaschewski, Mats Johnson, Michel Lecendreux, et al.CNS Drugs|November 8, 2013
Teriflunomide: a review of its use in relapsing multiple sclerosisKarly P Garnock-JonesPageof 211